Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Following the completion of the Genentech transaction Roche announced the successful start of the integration. Building on the long-standing and trustful relationship of the two companies, senior leaders from Genentech and Roche have made considerable progress in a short period of time to set the course for the integration. Currently Genentech Chairman and CEO, will chair Genentech's new Board of Directors and steer the integration of Genentech and Roche on a strategic level. The board will include Roche executives as well as external members. Arthur Levinson also will serve as an advisor to Genentech's Research and Early Development center, and will join the Scientific Resource Board, Genentech's external advisory group.

Today in Execs on the Move...keeping you current

Thomas H. Silberg to Retire as President and CEO of APP Pharmaceuticals, John Ducker Named as Successor
American Pharmaceutical Partners, 12/03/09

Cardinal Health names Carrie Cox to board of directors
Cardinal Health, 12/03/09

Medtronic Names Michael J. Coyle as Executive Vice President and Group President of Cardiology Businesses
Medtronic, 12/03/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address